Research
Periodic Report
Indian Markets Hit by Pharma Tariff Fears, Realty Sell-off, and Nuclear Sector Jitters
Indian Markets Hit by Pharma Tariff Fears, Realty Sell-off, and Nuclear Sector Jitters
Written by - Fisdom Research
Array
February 14, 2025
2 minutes
Array
Market Snapshot
Indian stocks have declined for the eighth straight session, marking their longest losing streak since February 2023.
Market sentiment remains weak due to global uncertainties and rising domestic risk aversion.
While domestic inflows have provided some stability, they have not been enough to offset the broader market decline.
Sectoral Trends
Sector Name
% Change
Sector Name
% Change
NIFTY IT
0.0
NIFTY PRIVATE BANK
-0.6
NIFTY FMCG
-0.3
NIFTY AUTO
-1.2
NIFTY FINANCIAL SERVICES
-0.4
NIFTY OIL & GAS
-1.5
NIFTY BANK
-0.5
NIFTY REALTY
-1.7
Top News
Pharma Stocks Decline: Indian pharmaceutical stocks fell 1-4% on February 14 amid concerns over potential US tariffs on drug imports, which could pressure margins and pricing competitiveness.
Realty Sector Under Pressure: Real estate stocks saw heavy selling, with Phoenix Mills, Raymond, and Godrej Properties falling over 3% each, while broader sector weakness pulled Nifty Realty lower.
Nuclear Energy Stocks Drop: Shares of nuclear-related companies like BHEL, L&T, and Kirloskar Brothers fell up to 6% as concerns grew over the impact of US-designed nuclear reactors on domestic players.
Eight Firms Set to Raise Over Rs 7,800 Crore.
Technical Outlook: Key Indices
Indices Name
Support
Resistance
Nifty
22,800-22,750
23,260
Bank Nifty
48,700
50,000
Top Gainers and Losers
Top Gainers
% Change
Top Losers
% Change
BRITANNIA
1.0
ADANIPORTS
-4.6
ICICIBANK
0.8
BEL
-4.4
NESTLEIND
0.8
ADANIENT
-4.3
Trade Ideas Update
Our trade ideas success rate has 62% over the past month, even with increased volatility in the benchmark index. Follow Trade Ideas for timely stock insights.
